Stryker Corporation (SYK)

NYQ – Real vaqt narxi. Valyuta: USD

294.56

+0.10 (0.03%)

Bozor ochiq: May 13, 2026, 9:43 AM EDT

07.05.2026

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease. “This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease,” said Kevin Lobo, Chair and CEO, Stryker.

07.05.2026

Stryker declares an $0.88 per share quarterly dividend

Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.

04.05.2026

Stock Of The Day: Is This The Bottom For Stryker?

Stryker Corporation (NYSE:SYK) shares are trading sideways on Monday. But that wasn't the case on Friday.

01.05.2026

Stryker Q1 Earnings & Sales Miss Estimates on Cyber Disruption

SYK misses Q1 earnings and revenue estimates as a cyber incident disrupts production, dents margins, and slows growth despite gains across key segments.

01.05.2026

Stryker Corporation (SYK) Q1 2026 Press Conference Call Transcript

30.04.2026

Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment

Brad Saar joins Sonablate board to support growth of non-invasive prostate cancer treatment to signal next phase of expansion for HIFU-based prostate care.

28.04.2026

Stryker to Report Q1 Earnings: What's in Store for the Stock?

SYK heads into Q1 earnings with strong procedure demand and robotic surgery growth, but tariff and cost pressures may test margins.

Videolar

No Data

There is no data to display

Press-relizlar

07.05.2026

Stryker Corporation (SYK)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Stryker Corporation (SYK)

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Stryker declares an $0.88 per share quarterly dividend

Stock Of The Day: Is This The Bottom For Stryker?

Stryker Q1 Earnings & Sales Miss Estimates on Cyber Disruption

Stryker Corporation (SYK) Q1 2026 Press Conference Call Transcript

Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment

Stryker to Report Q1 Earnings: What's in Store for the Stock?

Videolar

No Data

Press-relizlar

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Stryker declares an $0.88 per share quarterly dividend

Stock Of The Day: Is This The Bottom For Stryker?

Stryker Q1 Earnings & Sales Miss Estimates on Cyber Disruption

Stryker Corporation (SYK) Q1 2026 Press Conference Call Transcript

Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment

Stryker to Report Q1 Earnings: What's in Store for the Stock?

Videolar

No Data

Press-relizlar

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Stryker declares an $0.88 per share quarterly dividend

Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment

Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)

Search stocks

Stryker Corporation (SYK)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Stryker Corporation (SYK)

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Stryker declares an $0.88 per share quarterly dividend

Stock Of The Day: Is This The Bottom For Stryker?

Stryker Q1 Earnings & Sales Miss Estimates on Cyber Disruption

Stryker Corporation (SYK) Q1 2026 Press Conference Call Transcript

Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment

Stryker to Report Q1 Earnings: What's in Store for the Stock?

Videolar

No Data

Press-relizlar

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Stryker declares an $0.88 per share quarterly dividend

Stock Of The Day: Is This The Bottom For Stryker?

Stryker Q1 Earnings & Sales Miss Estimates on Cyber Disruption

Stryker Corporation (SYK) Q1 2026 Press Conference Call Transcript

Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment

Stryker to Report Q1 Earnings: What's in Store for the Stock?

Videolar

No Data

Press-relizlar

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Stryker declares an $0.88 per share quarterly dividend

Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment

Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)